- Antibiotics
- Corticosteroids
- Monoclonal Antibodies
- Immunosuppressant Drugs
- Others
Venous Leg Ulcer Treatment Market size was valued at USD 2,851.2 million in 2023, and is poised to grow at a CAGR of 5.3% from 2024-2030. Venous leg ulcers are most frequently brought on by infection, although they can also be brought on by diabetes, obesity, and ageing. If left untreated, venous leg ulcers can become exceedingly painful and quickly worsen into more dangerous conditions. Leg ulcers caused by venous blood flow can be treated using a variety of techniques. While some ulcer treatments call for surgery, others call for the use of drugs to aid in ulcer healing. The origin of the ulcer and the patient's symptoms will determine the best course of treatment for venous leg ulcers.
The global market provides a detailed overview and can be segmented by drug class, route of administration, distribution channel, and region. By drug class, the market has been segmented into antibiotics, corticosteroids, monoclonal antibodies, immunosuppressant drugs, and others. By route of administration, the market has been segmented into oral, parenteral, and topical. By distribution channel, the venous leg ulcer treatment market has been segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment continues its dominance during the forecast period share in the market owing to the increase in the hospitalization rate and the rise in hospital healthcare infrastructure.
Study Period
2024-2030Base Year
2023CAGR
5.3%Largest Market
North AmericaFastest Growing Market
Europe
Rising prevalence of venous leg ulcers globally to accelerate market growth worldwide. Apart from this, immobility, varicose veins, obesity, pregnancy, and previous deep vein thrombosis are some other factors that contribute to the development of venous leg ulcers. According to an article published by the national center for biotechnology information (NCBI) in 2010, the prevalence of venous leg ulcers in the U.S. is nearly 600,000 annually. Along with rising awareness among the patient population regarding available treatment options, and the increasing geriatric population is also poised to push the market growth.
By Drug Class
By Route of Administration
By Distribution Channel
The venous leg ulcer treatment market size was valued at USD 2,851.2 million in 2023, and is poised to grow at a CAGR of 5.3% from 2024-2030.
Cardinal Health, Inc. (U.S.), Genentech, Inc. (U.S.), Hoffmann La Roche Ltd. (Switzerland), Leap Therapeutics, Inc. (U.S.), Daval International Ltd. (U.K.)
North America is the fastest-growing region for the venous leg ulcer treatment market
Partnerships and acquisitions opted by leading players in the venous leg ulcer treatment market. Many players such as Integra life sciences, smith & nephew, Coloplast corp., and 3m. introducing innovative treatment options for venous leg ulcers, and expansion of sales channels are key strategies adopted by leading market players to retain their dominating position in the market.
1.Executive Summary |
2.Global Venous Leg Ulcer Treatment Market Introduction |
2.1.Global Venous Leg Ulcer Treatment Market - Taxonomy |
2.2.Global Venous Leg Ulcer Treatment Market - Definitions |
2.2.1.Drug Class |
2.2.2.Route of Administration |
2.2.3.Distribution Channel |
2.2.4.Region |
3.Global Venous Leg Ulcer Treatment Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Venous Leg Ulcer Treatment Market Analysis, 2019-2023 and Forecast 2024-2030 |
4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Venous Leg Ulcer Treatment Market By Drug Class, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
5.1. Antibiotics |
5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Corticosteroids |
5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Monoclonal Antibodies |
5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Immunosuppressant Drugs |
5.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Others |
5.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
6.Global Venous Leg Ulcer Treatment Market By Route of Administration, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
6.1. Oral |
6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Parental |
6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Topical |
6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7.Global Venous Leg Ulcer Treatment Market By Distribution Channel, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
7.1. Hospital Pharmacies |
7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Retail Pharmacies |
7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Online Pharmacies |
7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8.Global Venous Leg Ulcer Treatment Market By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America Venous Leg Ulcer Treatment Market 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
9.1. Drug Class Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Antibiotics |
9.1.2.Corticosteroids |
9.1.3.Monoclonal Antibodies |
9.1.4.Immunosuppressant Drugs |
9.1.5.Others |
9.2. Route of Administration Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Oral |
9.2.2.Parental |
9.2.3.Topical |
9.3. Distribution Channel Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospital Pharmacies |
9.3.2.Retail Pharmacies |
9.3.3.Online Pharmacies |
9.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe Venous Leg Ulcer Treatment Market 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
10.1. Drug Class Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Antibiotics |
10.1.2.Corticosteroids |
10.1.3.Monoclonal Antibodies |
10.1.4.Immunosuppressant Drugs |
10.1.5.Others |
10.2. Route of Administration Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Oral |
10.2.2.Parental |
10.2.3.Topical |
10.3. Distribution Channel Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospital Pharmacies |
10.3.2.Retail Pharmacies |
10.3.3.Online Pharmacies |
10.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
10.4.6.Rest of EU |
10.4.7. |
11.Asia Pacific (APAC) Venous Leg Ulcer Treatment Market 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
11.1. Drug Class Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Antibiotics |
11.1.2.Corticosteroids |
11.1.3.Monoclonal Antibodies |
11.1.4.Immunosuppressant Drugs |
11.1.5.Others |
11.2. Route of Administration Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Oral |
11.2.2.Parental |
11.2.3.Topical |
11.3. Distribution Channel Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospital Pharmacies |
11.3.2.Retail Pharmacies |
11.3.3.Online Pharmacies |
11.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) Venous Leg Ulcer Treatment Market 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
12.1. Drug Class Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Antibiotics |
12.1.2.Corticosteroids |
12.1.3.Monoclonal Antibodies |
12.1.4.Immunosuppressant Drugs |
12.1.5.Others |
12.2. Route of Administration Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Oral |
12.2.2.Parental |
12.2.3.Topical |
12.3. Distribution Channel Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospital Pharmacies |
12.3.2.Retail Pharmacies |
12.3.3.Online Pharmacies |
12.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America Venous Leg Ulcer Treatment Market 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
13.1. Drug Class Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Antibiotics |
13.1.2.Corticosteroids |
13.1.3.Monoclonal Antibodies |
13.1.4.Immunosuppressant Drugs |
13.1.5.Others |
13.2. Route of Administration Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Oral |
13.2.2.Parental |
13.2.3.Topical |
13.3. Distribution Channel Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospital Pharmacies |
13.3.2.Retail Pharmacies |
13.3.3.Online Pharmacies |
13.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Cardinal Health, Inc. (U.S.) |
14.2.2.Genentech, Inc. (U.S.) |
14.2.3.Hoffmann La Roche Ltd. (Switzerland) |
14.2.4.Leap Therapeutics, Inc. (U.S.) |
14.2.5.Daval International Ltd. (U.K.) |
14.2.6.RegeneRx Biopharmaceuticals, Inc. (U.S.) |
14.2.7.MediWound Ltd (Israel) |
15. Research Methodology |
16. Appendix and Abbreviations |